Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD

Allameh Tabatabai University

Status: Completed

Conditions: Attention Deficit Hyperactivity Disorder

Treatments: Drug: Ritalin; Other: Active Control; Other: Cognitive-Motor Rehabilitation

Study type: Interventional

Funder types: Other

Identifiers

NCT02780102

328/94/16090

Details and patient eligibility

About

The investigators administered a randomized controlled trial (RCT) through random assignment of children with ADHD into three different groups to compare the effects of cognitive-motor rehabilitation, immediate release methylphenidate, and an active control on the executive functioning, learning, and behavioral symptoms of children with ADHD.

Enrollment: 48 patients

Sex: Male

Ages: 9 to 12 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Receiving ADHD diagnosis
• aged between 9 and 12 years
• Intelligence Quotient (IQ)>90

Exclusion criteria

• Severe co-morbid disorders, such as depression, op-positional defiant disorder and conduct disorder
• A history of seizures during past 2 years
• Disability or handicap preventing the child from participating cognitive-motor exercises
• Sever medical conditions requiring immediate medical treatment

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

48 participants in 3 patient groups

Cognitive-Motor Rehabilitation

Experimental group

Description:

Cognitive-Motor Rehabilitation (CMR): 20 sixty-minute sessions of cognitive-motor rehabilitation

Treatment:

Other: Cognitive-Motor Rehabilitation

Ritalin

Experimental group

Description:

2 to 3 doses of 10 mg Ritalin tablets per day during 8 week.

Treatment:

Drug: Ritalin

Active Control

Active Comparator group

Description:

Active Control group simultaneously received 20 sixty-minute sessions of low dose cognitive-motor exercises

Treatment:

Other: Active Control